SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?

Authors: Yan Ling ONG, Apichat KAEWDECH, Yu Jun WONG

Published: 2025-03-13

DOI: 10.3350/cmh.2025.0257

Source: Full article

---

Abstract

No abstract found.